Yushi Matsuo
Overview
Explore the profile of Yushi Matsuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toyosaki M, Tsukadaira M, Matsuo Y, Sasaki J
Cureus
. 2025 Mar;
17(2):e78568.
PMID: 40062139
In Japan, malaria is rare, and only a few institutions have the diagnostic capabilities to treat it. In falciparum malaria, the symptoms and signs of the disease are non-specific, and...
2.
Uesato N, Kitagawa Y, Matsuo Y, Miyagawa N, Inagaki K, Kakefuda R, et al.
Biol Pharm Bull
. 2023 Sep;
46(9):1223-1230.
PMID: 37661402
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation and the destruction of bone and cartilage in affected joints. One of the unmet medical needs in the treatment of...
3.
Uesato N, Inagaki K, Miyagawa N, Kitagawa Y, Kakefuda R, Matsuo Y, et al.
Biol Pharm Bull
. 2020 Dec;
43(12):1884-1892.
PMID: 33268706
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and structural destruction of the joints. Bone damage occurs in an early stage after onset and osteoclast activation...
4.
Uesato N, Miyagawa N, Inagaki K, Kakefuda R, Kitagawa Y, Matsuo Y, et al.
Biol Pharm Bull
. 2020 Feb;
43(2):325-333.
PMID: 32009119
Colony stimulating factor 1 (CSF1) receptor (CSF1R) is a receptor protein-tyrosine kinase specifically expressed in monocyte-lineage cells, such as monocytes and macrophages. In this study, we characterized the pharmacological properties...
5.
Matsuo Y
Rinsho Byori
. 2017 Nov;
64(4):442-444.
PMID: 29182815
At the symposium entitled "challenging future of bio-bank business," the following topics were presented: 1) Bio-bank in the field of preemptive diagnosis by Prof. Saito (Fujita Health University), comprising personal...
6.
Shinagawa Y, Inoue T, Katsushima T, Kiguchi T, Ikenogami T, Ogawa N, et al.
ACS Med Chem Lett
. 2014 Jun;
2(3):238-42.
PMID: 24900301
Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified...
7.
Shintani M, Matsuo Y, Sakuraba S, Matubayasi N
Phys Chem Chem Phys
. 2012 Sep;
14(40):14049-60.
PMID: 22983117
The location, orientation, and dynamics of hydrophobic small molecules in lipid membranes are studied through combined use of solution-state (1)H-NMR and MD simulation. 1-Naphthol and 1-methylnaphthalene were adopted as the...
8.
Kimura S, Nakagawa T, Matsuo Y, Ishida Y, Okamoto Y, Hayashi M
Eur J Pharmacol
. 2011 Aug;
668(1-2):331-6.
PMID: 21810422
Intermittent administration of parathyroid hormone (PTH) has a potent anabolic effect on bone in humans and animals. Calcium-sensing receptor (CaSR) antagonists stimulate endogenous PTH secretion through CaSR on the surface...
9.
Shinagawa Y, Inoue T, Hirata K, Katsushima T, Nakagawa T, Matsuo Y, et al.
Bioorg Med Chem Lett
. 2010 May;
20(12):3809-13.
PMID: 20472433
Synthesis and structure-activity relationship studies on a new aminopropandiol class of derivatives as calcium-sensing receptor antagonists are described. Modification of the phenolic moiety of a calcilytic compound NPS 2143 led...